AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DIMERIX LTD

0.315

+0.0051.61%

Volume:587.10K

Turnover:182.34K

Market Cap:189.12M

PE:-11.26

High:0.315

Open:0.305

Low:0.305

Close:0.310

52wk High:0.665

52wk Low:0.157

Shares:600.40M

Float Shares:467.70M

Volume Ratio:0.43

T/O Rate:0.13%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.028

EPS(LYR):-0.024

ROE:-594.54%

ROA:-58.27%

PB:-112.50

PE(LYR):-13.32

Loading ...

Overview Company News Filings

Concept

Novel Coronavirus Treatment+2.33%

Pharmaceutical Companies+2.85%

Capital Flow

Inflow:

Outflow:

News

Dimerix Receives Initial $10 Million Upfront Payment Under Everest Medicines License Deal; Shares Gain 4%

MT Newswires Live

Dimerix Completes Transfer of Acute Kidney Injury Drug Candidate's US Investigational New Drug Application, Shares Up 6%

MT Newswires Live

Dimerix Ltd-Dimerix Assumes Sponsorship of US Ind for New Asset Dmx-652

THOMSON REUTERS

Soekarno-Hatta Set to Welcome Emirates' Giant A380

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/DXB.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"DXB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DXB.AU\",,,,,undefined,":{"symbol":"DXB.AU","market":"AU","secType":"STK","nameCN":"DIMERIX LTD","latestPrice":0.315,"timestamp":1787638320000,"preClose":0.31,"halted":0,"volume":587104,"delay":0,"changeRate":0.01612903225806453,"nameEN":"DIMERIX LTD","floatShares":467696880,"shares":600396776,"eps":-0.027967,"marketStatus":"Not Yet Opened","change":0.005,"latestTime":"08-25 16:12:00 AEST","open":0.305,"high":0.315,"low":0.305,"amount":182343,"amplitude":0.032258,"askPrice":0.315,"askSize":1686,"bidPrice":0.31,"bidSize":57809,"shortable":3,"etf":0,"ttmEps":-0.027967,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.31,"openAndCloseTimeList":[[1787616000000,1787637600000]],"volumeRatio":0.428829,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"DXB.AU","preClose":0.31,"auctionPrice":0.315,"auctionVolume":8225,"auction":3,"marketStatus":"盘后竞价","timestamp":1787638203501}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DXB.AU\",,,,,undefined,":{"symbol":"DXB.AU","floatShares":467696880,"roa":"-58.27%","roe":"-594.54%","lyrEps":-0.023645,"volumeRatio":0.428829,"shares":600396776,"dividePrice":0,"high":0.315,"amplitude":0.032258,"preClose":0.31,"low":0.305,"week52Low":0.157,"pbRate":"-112.50","psRate":"25.50","week52High":0.665,"institutionHeld":0,"latestPrice":0.315,"committee":0.943323,"eps":-0.027967,"divideRate":0,"volume":587104,"delay":0,"ttmEps":-0.027967,"open":0.305,"prevYearClose":0.55,"prevWeekClose":0.31,"prevMonthClose":0.245,"prevQuarterClose":0.205,"fiveDayClose":0.295,"twentyDayClose":0.25,"sixtyDayClose":0.185,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DXB.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DXB.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DXB.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660340889","title":"Dimerix Receives Initial $10 Million Upfront Payment Under Everest Medicines License Deal; Shares Gain 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660340889","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660340889?lang=en_us&edition=fundamental","pubTime":"2026-08-20 11:53","pubTimestamp":1787197984,"startTime":"0","endTime":"0","summary":"Dimerix  received an initial $10 million upfront payment under a license agreement with Everest Medicines, according to a Thursday filing with the Australian bourse.Everest holds exclusive rights to commercialize DMX-200 for the treatment of kidney disease focal segmental glomerulosclerosis across Greater China, South Korea, and Southeast Asia.Dimerix said it is eligible to receive up to an additional $330 million in success-based development, regulatory, and commercial milestone payments, in addition to tiered royalties on net sales of the DMX-200 in the licensed regions.The company's shares gained 4% in recent Thursday trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DXB.AU","MDCO","BK7067","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660243106","title":"Dimerix Completes Transfer of Acute Kidney Injury Drug Candidate's US Investigational New Drug Application, Shares Up 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660243106","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660243106?lang=en_us&edition=fundamental","pubTime":"2026-08-17 09:43","pubTimestamp":1786930994,"startTime":"0","endTime":"0","summary":"Dimerix  said it completed the transfer of the investigational new drug application in the US for its acute kidney injury drug candidate, DMX-652, from Mission Therapeutics, according to a Monday Australian bourse filing.Dimerix plans to advance DMX-652 into a phase 2 clinical trial for acute kidney injury associated with cardiac surgery during the second half, to investigate its potential to prevent kidney injury and preserve renal function.Its shares jumped 6% in recent trading on Monday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","DXB.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660875103","title":"Dimerix Ltd-Dimerix Assumes Sponsorship of US Ind for New Asset Dmx-652","url":"https://stock-news.laohu8.com/highlight/detail?id=2660875103","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660875103?lang=en_us&edition=fundamental","pubTime":"2026-08-17 06:38","pubTimestamp":1786919913,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260816:nTUE7JZ8SR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7501","BK7508","DXB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655355611","title":"Soekarno-Hatta Set to Welcome Emirates' Giant A380","url":"https://stock-news.laohu8.com/highlight/detail?id=2655355611","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655355611?lang=en_us&edition=fundamental","pubTime":"2026-07-31 12:54","pubTimestamp":1785473684,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta - Soekarno-Hatta International Airport, operated under InJourney Airports , is set to welcome the inaugural landing of Emirates Airlines' Airbus A380-800, which will operate flight EK358 from Dubai  to Jakarta .Soekarno-Hatta International Airport General Manager Heru Karyadi stated that the world's largest passenger airliner is scheduled to touch down in Jakarta on August 8, 2026, at 10:25 p.m. Jakarta time  before making its return journey to Dubai as flight EK359 on August 9, 2026, at 12:45 a.m. WIB.\"The arrival of the Airbus A380-800 is a major milestone in expanding Indonesia's international air connectivity,\" Heru said on Friday, July 31, 2026.","market":"hk","thumbnail":"https://statik.tempo.co/data/2023/06/02/id_1208747/1208747_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2023/06/02/id_1208747/1208747_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2116268/soekarno-hatta-set-to-welcome-emirates-giant-a380","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2116268/soekarno-hatta-set-to-welcome-emirates-giant-a380","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BK7501","BK7508","BK7067","PCR","DXB","DXB.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":11,"pageCount":1,"totalSize":44,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/DXB.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Novel Coronavirus Treatment","id":"package_au_concept_xgzlg","bkCode":"BK7501","changeRate":0.023275},{"market":"AU","name":"Pharmaceutical Companies","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.0285}]}}